Skip to content

Insider · CIK 0001407451

Laurence N Charney

director

Files at TGTX (TG THERAPEUTICS, INC.). First filing Nov 12, 2024, latest Sep 14, 2026.

Laurence N Charney files SEC Form 4 as director at TGTX (TG THERAPEUTICS, INC.). Since Nov 12, 2024, Laurence N Charney has reported 0 open-market buys worth $0 and 2 open-market sells worth $1.0M, the latest filed on Sep 14, 2026.

A track record needs three past buys with six months of prices behind them; Laurence N Charney has 0, so none is measured yet.

The newest scored trade: sold $275k of TGTX on Sep 10, 2026, filed Sep 14, 2026, scored 28 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $275k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.0M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TGTX: TG THERAPEUTICS, INC.

TGTXOct 9, 2026 · close 55.37

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
28Weak
TGTXsell
TG THERAPEUTICS, INC.
$275k
5,000 shares
-3%-
57Moderate
TGTXsell 3
TG THERAPEUTICS, INC.
$755k
25,000 shares
-11%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jan 2, 2026 KEN
Kenon Holdings Ltd.
6,000
63.85% of outstanding
$360kJan 2, 2026none
Jun 13, 2025 KEN
Kenon Holdings Ltd.
6,000
0.01% of outstanding
$208kJun 16, 2025none
Nov 12, 2024 TGTX
TG THERAPEUTICS, INC.
25,000
0.02% of outstanding
$755kNov 11, 2024none

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 10, 2026TGTX
TG THERAPEUTICS, INC.
SOpen-market sale
Common Stock
-5,000$54.96$275k168,64029 d ago
Jun 11, 2026TGTX
TG THERAPEUTICS, INC.
AGrant or award
Stock Tracking Unitderivative
+8,325$0.00$08,325Jun 15, 2026
Jan 28, 2026TGTX
TG THERAPEUTICS, INC.
GGift
Common Stock
-30,000$0.00$0192,887Jan 29, 2026
Jan 29, 2026TGTX
TG THERAPEUTICS, INC.
GGift
Common Stock
-13,197$0.00$0179,690Jan 29, 2026
Jun 12, 2025TGTX
TG THERAPEUTICS, INC.
AGrant or award
Common Stock
+21,408$0.00$0222,887Jun 16, 2025
Mar 10, 2025TGTX
TG THERAPEUTICS, INC.
GGift
Common Stock
-6,000$0.00$0201,479Mar 11, 2025
Nov 11, 2024TGTX
TG THERAPEUTICS, INC.
SOpen-market sale
Common Stock
-25,000$30.20$755k212,479Nov 12, 2024
Nov 12, 2024TGTX
TG THERAPEUTICS, INC.
GGift
Common Stock
-5,000$0.00$0207,479Nov 12, 2024

Questions about Laurence N Charney

Answered from the filings on this page, as of the latest one.

Is Laurence N Charney buying or selling?

In the last 12 months Laurence N Charney reported 0 open-market buys worth $0 and 1 open-market sell worth $275k on SEC Form 4; the latest was sold $275k of TGTX on Sep 10, 2026. Grants, option exercises and tax withholding are not counted.

How did Laurence N Charney's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Laurence N Charney has 0.

Where does Laurence N Charney file Form 4?

Laurence N Charney has filed Form 4 at TGTX (TG THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Laurence N Charney: insider trades and track record | InsiderTell